Neurofeedback therapy in psychiatric disorders

SEMERCİ SÖZÜER, ZEYNEP BENGİ; KÖSE, Samet

Neurofeedback therapy in psychiatric disorders

Samet KÖSE, (Vanderbilt University, Department of Psychiatry, Nashville, TN, USA)

ZEYNEP BENGİ SEMERCİ SÖZÜER (Yeditepe Üniversitesi, Tıp Fakültesi, Çocuk ve Ergen Psikiyatrisi Anabilim Dalı, İstanbul, Türkiye)

Klinik Psikofarmakoloji Bülteni

1 0

Yıl: 2010 Cilt: 20 Sayı: 3 Sayfa Aralığı: 193 - 195 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Neurofeedback therapy in psychiatric disorders

Öz:

Neurofeedback terapisi, beyin dalgalarının operant koşullama yöntemleriyle değiştirilebileceğine dayanan bir tedavi şeklidir. Neurofeedback (NF) terapi uygulayıcıları, değişik klinik koşullarda NF’in kullanımının olduğunu hatta sağlıklı bireylerde performans artımı için kullanılabileceğini ileri sürmüşlerdir. Yine de, NF terapisine ilişkin yayınlar güçlü kontroller içermediği ve metodolojik yetersizlikleri nedeniyle bilim ve araştırma çevrelerinin geniş bir kesimi tarafından ciddi biçimde eleştirilmiştir. NF uygulama alanı, hastalarda çoğunlukla yeterli eğitim almamış sıradan uygulayıcılar tarafından verilen yanlış ya da uygunsuz tedavi sonucu ortaya çıkan anlamlı ters etkilere neden olabilme potansiyelini taşımaktadır. Bu ters etkiler ve iyatrojenik tepkiler, NF pratisyenleri tarafından çoğu kez görmezlikten gelinmiştir. Bu makalede, NF terapisi uygulamasında karşılaşılan pratik ve etik sorunlara nasıl yanıt verileceği vurgulanmıştır.

Anahtar Kelime:

Konular: Farmakoloji ve Eczacılık

Psikiyatrik bozukluklarda Neurofeedback terapisi

Öz:

Neurofeedback therapy is a form of training where brainwave patterns can be modified by operant conditioning techniques. Neurofeedback therapy practitioners advocate the use of NF in several clinical conditions and even for performance enhancing in healthy subjects. However, the current published data lack strong controls, hence it has been criticisized by mainstream scientists and researchers. The NF field carries potentials for risks of having inappropriate treatments by lay practitioners that might cause severe adverse events in patients . These adverse events and iatrogenic reactions have often been ignored by the NF practitioners. Here, we emphasize the importance of good clinical practice and ethical guidelines that would address problems in standards of practice and ethical concerns in the field.

Anahtar Kelime:

Konular: Farmakoloji ve Eczacılık

Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık

1. Hammond DC. What is Neurofeedback? International Society for neurofeedback and Research. 2006; 10: 25-36.
2. Hoffman DA, Stockdale S, Van Egren L. EEG neurofeedback in the treatment of mild traumatic brain injury. Clinical Electroencephalography 1996; 27: 6.
3. Ayers ME. Neurofeedback for cerebral palsy. Journal of Neurotherapy 2004; 8: 93-94.
4. Walker JE, Kozlowski GP. Neurofeedback treatment of epilepsy. Child Adolesc Psychiatr Clin N Am. 2005;14:163-76
5. Baehr E, Rosenfeld JP, Baehr R. Clinical use of an alpha asymmetry neurofeedback protocol protocol in the treatment of mood disorders: follow-up study one to five years post therapy. Journal of Neurotherapy 2001; 4: 11-14.
6. Peniston EG, Kulkosky P. Alcoholic personality and alpha-theta brainwave training. Medical Psychotherapy 1991; 4: 47-60.
7. Burkett VS, Cummins JM, Dickson RM, Skolnick M. An open clinical trial utilizing real-time EEG operant conditioning as an adjunctive therapy in the treatment of crack cocaine dependence. Journal of Neurotherapy 2005; 9: 7-26.
8. Coben R, Myers TE. The relative efficacy of connectivity guided and symptom based EEG biofeedback for autistic disorders. Appl Psychophysiol Biofeedback. 2010;35:13-23.
9. Thompson L, Thompson M, Reid A. Neurofeedback outcomes in clients with Asperger’s syndrome. Appl Psychophysiol Biofeedback. 2010;35:63-81
10. Budzynsky TH. Brain brigthening: can neurofeedback improve cognitive process? Biofeedback 1996; 24: 14-17.
11. Egner T, Gruzelier JH. Ecological validity of neurofeedback: modulation of slow wave EEG enhances musical performance. Neuroreport 2002; 14: 1121-1224.
12. Hanslmayr S, Sauseng P, Doppelmayr M, Schabus M, Klimesch W. Increasing individual upper alpha power by neurofeedback improves cognitive performance in human subjects. Appl Psychophysiol Biofeedback. 2005;30:1-10.
13. Lubar JF, Shabsin HS, Natelson SE, Holder GS, Whitsett SF, Pamplin WE, Krulikowski DI. EEG operant conditioning in intractable epileptics. Arch Neurol 1981;38: 700-4.
14. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. Excess beta activity in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Res. 2001; 103:205- 18.
15. Lieberman MA, Yalom ID, Miles MB. Encounter groups: first facts. New York: Basic Books, 1973.
16. Hammond DC, Kirk L. First, do no harm: adverse effects and the need for practice standards in neurofeedback. J Neurother 2008; 12(1): 79-88.

APA	KÖSE S, SEMERCİ SÖZÜER Z (2010). Neurofeedback therapy in psychiatric disorders. , 193 - 195.
Chicago	KÖSE Samet,SEMERCİ SÖZÜER ZEYNEP BENGİ Neurofeedback therapy in psychiatric disorders. (2010): 193 - 195.
MLA	KÖSE Samet,SEMERCİ SÖZÜER ZEYNEP BENGİ Neurofeedback therapy in psychiatric disorders. , 2010, ss.193 - 195.
AMA	KÖSE S,SEMERCİ SÖZÜER Z Neurofeedback therapy in psychiatric disorders. . 2010; 193 - 195.
Vancouver	KÖSE S,SEMERCİ SÖZÜER Z Neurofeedback therapy in psychiatric disorders. . 2010; 193 - 195.
IEEE	KÖSE S,SEMERCİ SÖZÜER Z "Neurofeedback therapy in psychiatric disorders." , ss.193 - 195, 2010.
ISNAD	KÖSE, Samet - SEMERCİ SÖZÜER, ZEYNEP BENGİ. "Neurofeedback therapy in psychiatric disorders". (2010), 193-195.

APA	KÖSE S, SEMERCİ SÖZÜER Z (2010). Neurofeedback therapy in psychiatric disorders. Klinik Psikofarmakoloji Bülteni, 20(3), 193 - 195.
Chicago	KÖSE Samet,SEMERCİ SÖZÜER ZEYNEP BENGİ Neurofeedback therapy in psychiatric disorders. Klinik Psikofarmakoloji Bülteni 20, no.3 (2010): 193 - 195.
MLA	KÖSE Samet,SEMERCİ SÖZÜER ZEYNEP BENGİ Neurofeedback therapy in psychiatric disorders. Klinik Psikofarmakoloji Bülteni, vol.20, no.3, 2010, ss.193 - 195.
AMA	KÖSE S,SEMERCİ SÖZÜER Z Neurofeedback therapy in psychiatric disorders. Klinik Psikofarmakoloji Bülteni. 2010; 20(3): 193 - 195.
Vancouver	KÖSE S,SEMERCİ SÖZÜER Z Neurofeedback therapy in psychiatric disorders. Klinik Psikofarmakoloji Bülteni. 2010; 20(3): 193 - 195.
IEEE	KÖSE S,SEMERCİ SÖZÜER Z "Neurofeedback therapy in psychiatric disorders." Klinik Psikofarmakoloji Bülteni, 20, ss.193 - 195, 2010.
ISNAD	KÖSE, Samet - SEMERCİ SÖZÜER, ZEYNEP BENGİ. "Neurofeedback therapy in psychiatric disorders". Klinik Psikofarmakoloji Bülteni 20/3 (2010), 193-195.